FDA will review Moderna's data on vaccine for young kids without waiting for Pfizer.
Plus, an Ohio congressional candidate is hoping to flip a seat in the upcoming midterm election.The head of the Food and Drug Administration on Thursday said the agency would move along to review Moderna’s data for its kid vaccine regardless of when Pfizer submits its data on kids under five, a move that will be welcome news to some parents who were upset that waiting to authorize the vaccines together would delay the timeline.
A senior administration official also confirmed to ABC News the FDA would act"as expeditiously as possible" to authorize the Moderna vaccine, so long as it meets its standards.Dado Ruvic/Reuters In the meantime, Moderna's vaccine data is ready for review, though the company will continue to submit more data for its applications over the week or so.
“I think moms and dads and caregivers, doctors and nurses should be reassured by this result,” Burton told ABC News.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Baca lebih lajut »
Moderna Asks FDA to Clear Its Covid-19 Vaccine for Young ChildrenModerna asked the FDA to authorize its Covid-19 vaccine for children 6 months to 5 years. If regulators agree, vaccinations could begin by summer.
Baca lebih lajut »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Baca lebih lajut »
Moderna to ask FDA to authorize Covid-19 vaccine for young kidsThe request comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults.
Baca lebih lajut »
Moderna asks FDA to authorize first COVID-19 vaccine for very young children - Alaska Public MediaModerna announced Thursday that the company has asked the Food and Drug Administration to authorize a low-dose version of its COVID-19 vaccine as the first vaccine for children younger than age 5.
Baca lebih lajut »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenModerna announced Thursday that the company has asked the Food and Drug Administration to authorize a low-dose version of its COVID-19 vaccine as the first vaccine for children younger than age 5.
Baca lebih lajut »